Might salicylate exert benefits against childhood cancer?

19 Jan 2010

G Morgan, JI Johnsen

Childhood cancers are a broad range of diseases. Research on the chemopreventive potential of non-steroidal anti-inflammatory drugs, such as aspirin (acetylsalicylate) has yet to be fully directed towards childhood cancers. A prima facie hypothesis on salicylate and childhood cancer would therefore be based on several factors. Firstly, salicylate inhibits the production of inflammatory prostaglandins, which have been shown to stimulate the growth of cancer cells. Secondly, salicylate inhibits the growth of cancer cells in pre-clinical models. Thirdly, salicylate is a natural component of fruits and vegetables so it is consumed within the diet. Further research, of which some possibilities are identified, is recommended.

2071-the-global-cancer-crisis-a-review-of-growing-burden-deepening-inequality-and-initiatives-for-prevention-and-early-detection

Review: The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection

Charles M Balch, Ning Liao, Dennis S C Lam, Jeffrey N Weitzel, Rui-Hua Xu, Gerhardt Attard, Paul A Bunn, Alexander M M Eggermont, Jie He, Yuko Kitagawa, Soon Thye Lim, Eduardo Cazap, Bernard Esquivel, Xianqun Fan, Louis W C Chow, Edward S F Liu, Hector Martinez Said, John E Niederhuber, Isabel T Rubio, Ashraf Saad Zaghloul, Oscar G Arrieta, Riccardo A Audisio, Geerard L Beets, Felipe J F Coimbra, Jorge E Gallardo, Judy E Garber, Alessandro Gronchi, Volker Heinemann, Allison W Kurian, Miriam Mutebi, Masaki Mori, Funmi I Olopade, Piotr Rutkowski, Mansoor Saleh, William M Sanchez, Raymond Sawaya, John F Thompson, Gerald Tumusiime, Carlos S Vallejos, David C Whiteman, YiLong Wu, King-David T Yawe, Nayef Awad Al Zahrani, Odysseas Zoras, Banu K Arun, Carol J Fabian, Jeffrey E Gershenwald, William J Gradishar, Jin He, V Suzanne Kimberg, Ronald M K Lam, Victor H F Lee, Domenica Lorusso, Tony S K Mok, N D Perrier, Hope S Rugo, Cornelia Ulrich, Chandrakanth Are, J Vignat, I Soerjomataram

3 Feb 2026

https://doi.org/10.3332/ecancer.2026.2071

Abstract | Full Article | PDF

2068-nappocon-2025-translating-evidence-into-meaningful-clinical-practice-in-paediatric-psycho-oncology-reflections-from-the-first-national-paediatric-psycho-oncology-conference-1-2-august-2025-bangalore-india

Conference Report: NaPPOCON 2025: translating evidence into meaningful clinical practice in paediatric psycho-oncology—reflections from the First National Paediatric Psycho-Oncology Conference, 1–2 August 2025, Bangalore, India

Lakshmi R Varma, Krishna Gayathri Alakkal Rajesh, Sunil Bhat, Rhea Daruvala

30 Jan 2026

https://doi.org/10.3332/ecancer.2026.2068

Abstract | Full Article | PDF

2069-navigating-social-networks-in-cancer-care-a-phenomenological-exploration-of-patient-experiences

Research: Navigating social networks in cancer care: a phenomenological exploration of patient experiences

Yousef Roosta, Hero Khezri, Vahid Hoseinpour, Mohamad Jebraeily, Amirhossein Rayegani, Saeed Razavi-Dizaji

30 Jan 2026

https://doi.org/10.3332/ecancer.2026.2069

Abstract | Full Article | PDF

2067-a-report-from-the-second-tanzania-liver-cancer-conference-tlcc-2025-leading-the-fight-against-liver-cancer-in-sub-saharan-africa

Conference Report: A report from the Second Tanzania Liver Cancer Conference (TLCC) 2025 – leading the fight against liver cancer in Sub-Saharan Africa

Ally H Mwanga, Jeanine Justiniano, Eric M Mbuguje, Balowa Musa, Deogratius B Mwanakulya, Andrew Swallow, Edith Kimambo, Eva Uiso, Swaleh Pazi, Latifa Rajab, Nashivai E Kivuyo, Larry Akoko, Azza Naif, Advera Ngaiza, Sara Nyagabona, Jerry Ndumbalo, Amos R Mwakigonja, Jim E Littlejohn, Seif Wibonela, Cameron E Gaskill

22 Jan 2026

https://doi.org/10.3332/ecancer.2026.2067

Abstract | Full Article | PDF